Trial Profile
An Open-label Exploratory Study of the Pharmacokinetic Interaction of CXA-10 Administered to Steady State With Pravastatin and Vytorin (Simvastatin and Ezetimibe) in Healthy Males
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; IMR-261 (Primary) ; Pravastatin (Primary)
- Indications Acute kidney injury; Renal failure
- Focus Pharmacokinetics
- Sponsors Complexa
- 01 Sep 2018 Results published in the Clinical Pharmacology in Drug Development
- 02 May 2016 Status changed from recruiting to completed.
- 16 Sep 2015 New trial record